Kiora Pharmaceuticals, Inc. (KPRX)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
KPRX Insider Trading Activity
KPRX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $95,206 | 9 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Parsons Erin | director | 1 | $25,669 | 0 | $0 | $25,669 |
| TYLE PRAVEEN | director | 1 | $19,800 | 0 | $0 | $19,800 |
| Strem Brian M. | President and CEO | 1 | $14,997 | 0 | $0 | $14,997 |
| Shapiro Aron | director | 1 | $10,800 | 0 | $0 | $10,800 |
| Daniels Eric Joseph | Chief Development Officer | 1 | $7,570 | 0 | $0 | $7,570 |
| Tosca Melissa | EVP Finance | 2 | $6,945 | 0 | $0 | $6,945 |
| Walters-Hoffert Lisa | director | 1 | $4,825 | 0 | $0 | $4,825 |
| Stengone Carmine N. | director | 1 | $4,600 | 0 | $0 | $4,600 |
About Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid …
Insider Activity of Kiora Pharmaceuticals, Inc.
Over the last 12 months, insiders at Kiora Pharmaceuticals, Inc. have bought $95,206 and sold $0 worth of Kiora Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Kiora Pharmaceuticals, Inc. have bought $2.71M and sold $15.19M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Parsons Erin (director) — $25,669. TYLE PRAVEEN (director) — $19,800. Strem Brian M. (President and CEO) — $14,997.
The last purchase of 1,250 shares for transaction amount of $4,600 was made by Stengone Carmine N. (director) on 2024‑09‑11.
List of Insider Buy and Sell Transactions, Kiora Pharmaceuticals, Inc.
| 2024-09-11 | Stengone Carmine N. | director | 1,250 0.0442% | $3.68 | $4,600 | -2.51% | ||
| 2024-09-10 | Shapiro Aron | director | 3,000 0.1039% | $3.60 | $10,800 | -0.29% | ||
| 2024-08-19 | TYLE PRAVEEN | director | 5,000 0.165% | $3.96 | $19,800 | -13.37% | ||
| 2024-08-19 | Walters-Hoffert Lisa | director | 1,250 0.0402% | $3.86 | $4,825 | -13.37% | ||
| 2024-08-14 | Tosca Melissa | CFO | 2,000 0.0667% | $3.21 | $6,420 | +12.90% | ||
| 2024-06-14 | Daniels Eric Joseph | Chief Development Officer | 1,431 0.0556% | $5.29 | $7,570 | -33.40% | ||
| 2024-06-14 | Tosca Melissa | EVP Finance | 100 0.0039% | $5.25 | $525 | -33.40% | ||
| 2024-06-13 | Strem Brian M. | President and CEO | 3,000 0.1101% | $5.00 | $14,997 | -26.24% | ||
| 2024-06-13 | Parsons Erin | director | 5,260 0.1885% | $4.88 | $25,669 | -26.24% | ||
| 2021-11-18 | Strem Brian M. | President and CEO | 17,853 0.1764% | $1.41 | $25,173 | -68.88% | ||
| 2021-08-02 | Sale | ARMISTICE CAPITAL, LLC | 10 percent owner | 192,775 1.8717% | $2.40 | $463,046 | -69.80% | |
| 2021-07-30 | Sale | ARMISTICE CAPITAL, LLC | 10 percent owner | 68,188 0.7096% | $2.69 | $183,562 | -70.83% | |
| 2021-07-29 | Sale | ARMISTICE CAPITAL, LLC | 400,000 4.0311% | $3.00 | $1.2M | -74.57% | ||
| 2021-07-28 | Sale | ARMISTICE CAPITAL, LLC | 375,443 3.7408% | $3.28 | $1.23M | -76.79% | ||
| 2021-07-27 | Sale | ARMISTICE CAPITAL, LLC | 2.38M 31.3018% | $5.09 | $12.11M | -79.90% | ||
| 2021-01-06 | ARMISTICE CAPITAL, LLC | 1.53M 21.542% | $5.22 | $8M | -32.02% | |||
| 2020-02-10 | ARMISTICE CAPITAL, LLC | 12,000 0.2683% | $6.04 | $72,480 | -18.43% | |||
| 2020-02-06 | ARMISTICE CAPITAL, LLC | 11,000 0.2463% | $6.18 | $67,980 | -20.16% | |||
| 2019-12-06 | Sale | GOLDBERG MORTON | director | 1,961 0.0619% | $6.93 | $13,590 | -27.54% | |
| 2019-11-12 | Sale | GOLDBERG MORTON | director | 2,001 0.06% | $4.29 | $8,584 | +12.00% |
Insider Historical Profitability
| Strem Brian M. | President and CEO | 14531 0.4842% | $47,080.44 | 2 | 0 | <0.0001% |
| Tosca Melissa | CFO | 13599 0.4532% | $44,060.76 | 2 | 0 | |
| Daniels Eric Joseph | Chief Development Officer | 11222 0.374% | $36,359.28 | 1 | 0 | |
| Parsons Erin | director | 5260 0.1753% | $17,042.40 | 1 | 0 | |
| TYLE PRAVEEN | director | 5014 0.1671% | $16,245.36 | 1 | 0 |
Historical Insider Profitability vs. Competitors
$8,253,997 | 122 | -53.40% | $11.34M | |
$1,724,269 | 63 | -16.36% | $12.25M | |
$1,226,605 | 43 | -21.28% | $7.98M | |
$383,884 | 32 | -25.10% | $12.65M | |
$95,303,339 | 30 | -13.78% | $10.77M |
KPRX Institutional Investors: Active Positions
| Increased Positions | 3 | +11.54% | 5,145 | +0.35% |
| Decreased Positions | 9 | -34.62% | 214,809 | -14.62% |
| New Positions | <1 | New | <1 | New |
| Sold Out Positions | 4 | Sold Out | 207,276 | Sold Out |
| Total Postitions | 20 | -23.08% | 1M | -14.27% |
KPRX Ownership Change vs Market
Institutional Investor Ownership
| Aigh Capital Management Llc | $828.00 | 8.52% | 255,555 | 0 | 0% | 2024-12-31 |
| Rosalind Advisors, Inc. | $812.00 | 8.35% | 250,555 | -5,000 | -1.96% | 2024-12-31 |
| Nantahala Capital Management, Llc | $684.00 | 7.04% | 211,110 | 0 | 0% | 2024-12-31 |
| Stonepine Capital Management, Llc | $651.00 | 6.7% | 200,970 | -1,430 | -0.71% | 2024-12-31 |
| Adar1 Capital Management, Llc | $649.00 | 6.67% | 200,221 | +3,670 | +1.87% | 2024-12-31 |
| Velan Capital Investment Management Lp | $396.00 | 4.07% | 122,223 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $52.00 | 0.53% | 15,957 | +1,474 | +10.18% | 2024-12-31 |
| Blackrock, Inc. | $5.00 | 0.05% | 1,606 | 0 | 0% | 2024-12-31 |
| Tower Research Capital Llc (Trc) | $4.00 | 0.04% | 1,205 | -749 | -38.33% | 2024-12-31 |
| Newedge Advisors, Llc | $0 | <0.01% | 22 | 0 | 0% | 2024-12-31 |